The School of Medicine at the University of California, Riverside, has received a grant aimed at halting further isolation of people aging with HIV during the COVID-19 pandemic.
The two-year, $245,000 grant from the multinational pharmaceutical company Merck will enable a study, starting later this month, involving the participation of people living with HIV, or PLWH, in Riverside County, Los Angeles, and the Tampa Bay area in Florida.